Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/29254858 below:

Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial

Randomized Controlled Trial

Collaborators, Affiliations

• SCOOP Study Team: Lee Shepstone, Elizabeth Lenaghan, Cyrus Cooper, Shane Clarke, Rebekah Fong-Soe-Khioe, Ric Fordham, Neil Gittoes, Ian Harvey, Nick Harvey, Alison Heawood, Richard Holland, Amanda Howe, John Kanis, Tarnya Marshall, Terence O'Neill, Tim Peters, Niamh Redmond, David Torgerson, David Turner, Eugene McCloskey, Nicola Crabtree, Helen Duffy, Jim Parle, Farzana Rashid, Katie Stant, Kate Taylor, Clare Thomas, Emma Knox, Cherry Tenneson, Helen Williams, David Adams, Veronica Bion, Jeanette Blacklock, Tony Dyer, Selina Bratherton, Matt Fidler, Katharine Knight, Carol McGurk, Katie Smith, Stacey Young, Karen Collins, Janet Cushnaghan, Catherine Arundel, Kerry Bell, Laura Clark, Sue Collins, Sarah Gardner, Natasha Mitchell

• ¹ School of Medicine, University of East Anglia, Norwich, UK. Electronic address: l.shepstone@uea.ac.uk.
• ² School of Medicine, University of East Anglia, Norwich, UK.
• ³ Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK.
• ⁴ Department of Rheumatology, University Hospitals Bristol, Bristol, UK.
• ⁵ Centre for Endocrinology, Diabetes and Metabolism, Queen Elizabeth Hospital, Birmingham, UK.
• ⁶ Bristol Medical School, University of Bristol, Bristol, UK.
• ⁷ Leicester Medical School, Centre for Medicine, University of Leicester, UK.
• ⁸ Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK; Australian Catholic University, Melbourne, VIC, Australia.
• ⁹ Norfolk and Norwich University Hospital, Norwich, UK.
• ¹⁰ National Institute of Health Research Manchester Musculoskeletal BRU, Central Manchester University Hospitals NHS Foundation Trust & Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, UK.
• ¹¹ Department of Health Sciences, University of York, York, UK.
• ¹² Mellanby Centre for Bone Research, Centre for Integrated Research into Musculoskeletal Ageing, University of Sheffield, Sheffield, UK.

• PMID: 29254858
• DOI: 10.1016/S0140-6736(17)32640-5

Item in Clipboard

Randomized Controlled Trial

Lee Shepstone et al. Lancet. 2018.

• SCOOP Study Team: Lee Shepstone, Elizabeth Lenaghan, Cyrus Cooper, Shane Clarke, Rebekah Fong-Soe-Khioe, Ric Fordham, Neil Gittoes, Ian Harvey, Nick Harvey, Alison Heawood, Richard Holland, Amanda Howe, John Kanis, Tarnya Marshall, Terence O'Neill, Tim Peters, Niamh Redmond, David Torgerson, David Turner, Eugene McCloskey, Nicola Crabtree, Helen Duffy, Jim Parle, Farzana Rashid, Katie Stant, Kate Taylor, Clare Thomas, Emma Knox, Cherry Tenneson, Helen Williams, David Adams, Veronica Bion, Jeanette Blacklock, Tony Dyer, Selina Bratherton, Matt Fidler, Katharine Knight, Carol McGurk, Katie Smith, Stacey Young, Karen Collins, Janet Cushnaghan, Catherine Arundel, Kerry Bell, Laura Clark, Sue Collins, Sarah Gardner, Natasha Mitchell

• ¹ School of Medicine, University of East Anglia, Norwich, UK. Electronic address: l.shepstone@uea.ac.uk.
• ² School of Medicine, University of East Anglia, Norwich, UK.
• ³ Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK.
• ⁴ Department of Rheumatology, University Hospitals Bristol, Bristol, UK.
• ⁵ Centre for Endocrinology, Diabetes and Metabolism, Queen Elizabeth Hospital, Birmingham, UK.
• ⁶ Bristol Medical School, University of Bristol, Bristol, UK.
• ⁷ Leicester Medical School, Centre for Medicine, University of Leicester, UK.
• ⁸ Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK; Australian Catholic University, Melbourne, VIC, Australia.
• ⁹ Norfolk and Norwich University Hospital, Norwich, UK.
• ¹⁰ National Institute of Health Research Manchester Musculoskeletal BRU, Central Manchester University Hospitals NHS Foundation Trust & Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, UK.
• ¹¹ Department of Health Sciences, University of York, York, UK.
• ¹² Mellanby Centre for Bone Research, Centre for Integrated Research into Musculoskeletal Ageing, University of Sheffield, Sheffield, UK.

• PMID: 29254858
• DOI: 10.1016/S0140-6736(17)32640-5

Item in Clipboard

Background: Despite effective assessment methods and medications targeting osteoporosis and related fractures, screening for fracture risk is not currently advocated in the UK. We tested whether a community-based screening intervention could reduce fractures in older women.

Methods: We did a two-arm randomised controlled trial in women aged 70-85 years to compare a screening programme using the Fracture Risk Assessment Tool (FRAX) with usual management. Women were recruited from 100 general practitioner (GP) practices in seven regions of the UK: Birmingham, Bristol, Manchester, Norwich, Sheffield, Southampton, and York. We excluded women who were currently on prescription anti-osteoporotic drugs and any individuals deemed to be unsuitable to enter a research study (eg, known dementia, terminally ill, or recently bereaved). The primary outcome was the proportion of individuals who had one or more osteoporosis-related fractures over a 5-year period. In the screening group, treatment was recommended in women identified to be at high risk of hip fracture, according to the FRAX 10-year hip fracture probability. Prespecified secondary outcomes were the proportions of participants who had at least one hip fracture, any clinical fracture, or mortality; and the effect of screening on anxiety and health-related quality of life. This trial is registered with the International Standard Randomised Controlled Trial registry, number ISRCTN 55814835.

Findings: 12 483 eligible women were identified and participated in the trial, and 6233 women randomly assigned to the screening group between April 15, 2008, and July 2, 2009. Treatment was recommended in 898 (14%) of 6233 women. Use of osteoporosis medication was higher at the end of year 1 in the screening group compared with controls (15% vs 4%), with uptake particularly high (78% at 6 months) in the screening high-risk subgroup. Screening did not reduce the primary outcome of incidence of all osteoporosis-related fractures (hazard ratio [HR] 0·94, 95% CI 0·85-1·03, p=0·178), nor the overall incidence of all clinical fractures (0·94, 0·86-1·03, p=0·183), but screening reduced the incidence of hip fractures (0·72, 0·59-0·89, p=0·002). There was no evidence of differences in mortality, anxiety levels, or quality of life.

Interpretation: Systematic, community-based screening programme of fracture risk in older women in the UK is feasible, and could be effective in reducing hip fractures.

Funding: Arthritis Research UK and Medical Research Council.

Copyright © 2018 Elsevier Ltd. All rights reserved.

PubMed Disclaimer

• A two-step screening process reduces hip fractures.

  Cauley JA. Cauley JA. Lancet. 2018 Feb 24;391(10122):715-716. doi: 10.1016/S0140-6736(17)33295-6. Epub 2017 Dec 16. Lancet. 2018. PMID: 29254857 No abstract available.

• Osteoporosis: Community-based screening reduces hip fracture risk.

  Bradley CA. Bradley CA. Nat Rev Endocrinol. 2018 Mar;14(3):129. doi: 10.1038/nrendo.2018.2. Epub 2018 Jan 19. Nat Rev Endocrinol. 2018. PMID: 29348475 No abstract available.

• [Journal Club].

  Dovjak P. Dovjak P. Z Gerontol Geriatr. 2018 Jun;51(4):478. doi: 10.1007/s00391-018-1408-6. Z Gerontol Geriatr. 2018. PMID: 29797046 German. No abstract available.

• Building a cultural alliance for the prevention of fragility fractures among high risk older adults.

  Baroni M, Prenni V, Ruggiero C. Baroni M, et al. Ann Transl Med. 2018 Jun;6(11):227. doi: 10.21037/atm.2018.04.38. Ann Transl Med. 2018. PMID: 30023390 Free PMC article. No abstract available.

• A closer look at SCOOP: screening for fracture prevention.

  Bolland MJ, Grey A. Bolland MJ, et al. Lancet. 2018 Aug 18;392(10147):551-552. doi: 10.1016/S0140-6736(18)31378-3. Epub 2018 Aug 16. Lancet. 2018. PMID: 30152382 No abstract available.

• A closer look at SCOOP: screening for fracture prevention - Authors' reply.

  Shepstone L, McCloskey E; SCOOP study team. Shepstone L, et al. Lancet. 2018 Aug 18;392(10147):552-553. doi: 10.1016/S0140-6736(18)31385-0. Epub 2018 Aug 16. Lancet. 2018. PMID: 30152384 No abstract available.

• A closer look at SCOOP: screening for fracture prevention.

  Swart KMA, Merlijn T, Netelenbos JC, Elders PJM. Swart KMA, et al. Lancet. 2018 Aug 18;392(10147):552. doi: 10.1016/S0140-6736(18)31379-5. Epub 2018 Aug 16. Lancet. 2018. PMID: 30152385 No abstract available.

• Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip Fractures-A Post Hoc Analysis of the SCOOP Study.

  McCloskey E, Johansson H, Harvey NC, Shepstone L, Lenaghan E, Fordham R, Harvey I, Howe A, Cooper C, Clarke S, Gittoes N, Heawood A, Holland R, Marshall T, O'Neill TW, Peters TJ, Redmond N, Torgerson D, Kanis JA; SCOOP Study Team. McCloskey E, et al. J Bone Miner Res. 2018 Jun;33(6):1020-1026. doi: 10.1002/jbmr.3411. Epub 2018 Mar 23. J Bone Miner Res. 2018. PMID: 29480960 Free PMC article.

• Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study.

  Söreskog E, Borgström F, Shepstone L, Clarke S, Cooper C, Harvey I, Harvey NC, Howe A, Johansson H, Marshall T, O'Neill TW, Peters TJ, Redmond NM, Turner D, Holland R, McCloskey E, Kanis JA; SCOOP study team. Söreskog E, et al. Osteoporos Int. 2020 Aug;31(8):1499-1506. doi: 10.1007/s00198-020-05372-6. Epub 2020 Apr 1. Osteoporos Int. 2020. PMID: 32239237 Free PMC article. Clinical Trial.

• Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study.

  Condurache CI, Chiu S, Chotiyarnwong P, Johansson H, Shepstone L, Lenaghan E, Cooper C, Clarke S, Khioe RFS, Fordham R, Gittoes N, Harvey I, Harvey NC, Heawood A, Holland R, Howe A, Kanis JA, Marshall T, O'Neill TW, Peters TJ, Redmond NM, Torgerson D, Turner D, McCloskey E; SCOOP Study Team. Condurache CI, et al. Osteoporos Int. 2020 Mar;31(3):457-464. doi: 10.1007/s00198-019-05270-6. Epub 2020 Jan 20. Osteoporos Int. 2020. PMID: 31960099

• Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

  Viswanathan M, Reddy S, Berkman N, Cullen K, Middleton JC, Nicholson WK, Kahwati LC. Viswanathan M, et al. JAMA. 2018 Jun 26;319(24):2532-2551. doi: 10.1001/jama.2018.6537. JAMA. 2018. PMID: 29946734 Review.

• A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures.

  Davis S, Martyn-St James M, Sanderson J, Stevens J, Goka E, Rawdin A, Sadler S, Wong R, Campbell F, Stevenson M, Strong M, Selby P, Gittoes N. Davis S, et al. Health Technol Assess. 2016 Oct;20(78):1-406. doi: 10.3310/hta20780. Health Technol Assess. 2016. PMID: 27801641 Free PMC article. Review.

• Definition and management of very high fracture risk in women with postmenopausal osteoporosis: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Association of Bone Assessment and Metabolism (ABRASSO).

  Silva BC, Madeira M, d'Alva CB, Maeda SS, de Holanda NCP, Ohe MN, Szejnfeld V, Zerbini CAF, de Paula FJA, Bandeira F. Silva BC, et al. Arch Endocrinol Metab. 2022 Nov 11;66(5):591-603. doi: 10.20945/2359-3997000000522. Epub 2022 Oct 3. Arch Endocrinol Metab. 2022. PMID: 36191263 Free PMC article.

• East meets West: current practices and policies in the management of musculoskeletal aging.

  Xia W, Cooper C, Li M, Xu L, Rizzoli R, Zhu M, Lin H, Beard J, Ding Y, Yu W, Cavalier E, Zhang Z, Kanis JA, Cheng Q, Wang Q, Reginster JY. Xia W, et al. Aging Clin Exp Res. 2019 Oct;31(10):1351-1373. doi: 10.1007/s40520-019-01282-8. Epub 2019 Aug 2. Aging Clin Exp Res. 2019. PMID: 31376119 Free PMC article. Review.

• Muscle size and density are independently associated with death after hip fracture: A prospective cohort study.

  Wang L, Yang M, Ge Y, Liu Y, Su Y, Guo Z, Huang P, Geng J, Wang G, Blake GM, He B, Yin L, Cheng X, Wu X, Engelke K, Vlug AG. Wang L, et al. J Cachexia Sarcopenia Muscle. 2023 Aug;14(4):1824-1835. doi: 10.1002/jcsm.13261. Epub 2023 May 19. J Cachexia Sarcopenia Muscle. 2023. PMID: 37208980 Free PMC article.

• Hip structural analysis parameters are not associated with the risk of postmenopausal female second hip fracture: a retrospective study.

  Ma Y, Ge Y, Guo Z, Su Y, Wang C, Wang Q, Wang L, Cheng X, Yang M, Yan D. Ma Y, et al. BMC Musculoskelet Disord. 2025 Mar 10;26(1):233. doi: 10.1186/s12891-025-08368-7. BMC Musculoskelet Disord. 2025. PMID: 40065296 Free PMC article.

• Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures.

  McCloskey EV, Harvey NC, Johansson H, Lorentzon M, Vandenput L, Liu E, Kanis JA. McCloskey EV, et al. Osteoporos Int. 2021 Jan;32(1):39-46. doi: 10.1007/s00198-020-05542-6. Epub 2020 Oct 14. Osteoporos Int. 2021. PMID: 33057738 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3